Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 1989 | 2019 | |||||||||
|
hepatocyte nuclear factor 4 alpha | 0.461 | 0.808 | 0.15 |
|
disease | 1.000 | None | 0.942 | 3 | 2 | 1992 | 2019 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
disease | 0.900 | strong | 0.953 | 2 | 2 | 1992 | 2020 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.900 | strong | 0.954 | 2 | 2 | 1995 | 2019 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
disease | 0.900 | strong | 0.943 | 11 | 3 | 1996 | 2019 | ||||||||
|
HNF1 homeobox B | 0.473 | 0.808 | 1.00 |
|
disease | 0.800 | None | 0.978 | 5 | 5 | 1998 | 2019 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.700 | None | 0.953 | 2 | 2 | 1998 | 2020 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.400 | None | 1.000 | 1 | 1 | 2000 | 2019 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
disease | 0.700 | strong | 0.974 | 5 | 5 | 2002 | 2020 | ||||||||
|
adenylate cyclase 5 | 0.617 | 0.577 | 1.00 |
|
disease | 0.700 | None | 0.947 | 3 | 2 | 2002 | 2019 | ||||||||
|
sterol regulatory element binding transcription factor 1 | 0.518 | 0.808 | 1.5E-02 |
|
disease | 0.400 | None | 0.938 | 1 | 1 | 2002 | 2019 | ||||||||
|
glucokinase regulator | 0.604 | 0.615 | 8.5E-19 |
|
disease | 0.500 | None | 0.957 | 2 | 1 | 2005 | 2020 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.965 | 25 | 9 | 2006 | 2020 | ||||||||
|
activating transcription factor 6 | 0.516 | 0.846 | 3.2E-07 |
|
disease | 0.180 | None | 0.889 | 1 | 4 | 2006 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.670 | None | 1.000 | 1 | 1 | 2006 | 2020 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.700 | None | 0.984 | 21 | 86 | 2007 | 2019 | ||||||||
|
insulin like growth factor 2 mRNA binding protein 2 | 0.588 | 0.615 | 0.24 |
|
disease | 0.500 | None | 0.972 | 18 | 26 | 2007 | 2019 | ||||||||
|
solute carrier family 30 member 8 | 0.623 | 0.731 | 7.4E-12 |
|
disease | 0.500 | None | 0.963 | 15 | 3 | 2007 | 2019 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.500 | None | 0.954 | 11 | 16 | 2007 | 2020 | ||||||||
|
notch receptor 2 | 0.441 | 0.808 | 1.00 |
|
disease | 0.460 | None | 1.000 | 4 | 1 | 2007 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.180 | None | 1.000 | 2 | 2 | 2007 | 2019 | |||||||||
|
calmodulin binding transcription activator 1 | 0.599 | 0.615 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2007 | 2011 | ||||||||
|
aspartyl-tRNA synthetase 2, mitochondrial | 0.638 | 0.577 | 9.8E-13 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
long intergenic non-protein coding RNA 844 | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2007 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2007 | 2017 |